Having been at the flag-raising ceremony for Hospira when it spun out of Abbott back in 2004, the news of Pfizer’s acquisition was a bit emotional for me. I didn’t cry or anything, but I did feel a little sad, and a little proud, and maybe a little hopeful at the end of the day.
Medtech M&A: Tips from the front lines
S2N recently hosted an informal gathering of emerging med tech CEOs, a sort of group therapy session for people suffering from the form of temporary insanity that makes one want to be a healthcare entrepreneur.